Disclosure Context
Salem Erode Investments Limited submitted a regulatory disclosure to BSE Limited under Regulation 30, read with Part A of Schedule III, Regulation 33 and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The disclosure pertains to the outcome of the Board Meeting held on August 13, 2026.
Financial Results Overview (₹ in Lacs)
Income Statement
Total Income: ₹90.90 lakh (Q1 FY2027) vs ₹110.19 lakh (Q1 FY2026)
- Revenue from Operations: ₹89.38 lakh (Q1 FY2027) vs ₹108.88 lakh (Q1 FY2026)
- Other Income: ₹1.52 lakh (Q1 FY2027) vs ₹1.31 lakh (Q1 FY2026)
Expenses: ₹216.92 lakh (Q1 FY2027) vs ₹209.16 lakh (Q1 FY2026)
- Finance Costs: ₹43.82 lakh
- Impairment on financial instruments (net): ₹1.39 lakh
- Employee benefits expense: ₹25.76 lakh
- Depreciation & amortisation expenses: ₹50.25 lakh
- Administrative and other expenses: ₹95.70 lakh
Profit before Exceptional Items and Tax: Loss of ₹126.02 lakh (Q1 FY2027) vs Loss of ₹98.97 lakh (Q1 FY2026)
Tax Expenses: ₹4.95 lakh (Deferred Tax)
Profit after tax: Loss of ₹130.97 lakh (Q1 FY2027) vs Loss of ₹98.98 lakh (Q1 FY2026)
Other Comprehensive Income: ₹1.10 lakh (net of tax)
Total Comprehensive Income: Loss of ₹129.87 lakh (Q1 FY2027) vs Loss of ₹98.28 lakh (Q1 FY2026)
Key Metrics
Paid up Equity Share Capital: ₹114.66 lakh (Face Value per share ₹1)
Earnings Per Share: Basic and Diluted (not annualized) Loss of ₹1.14 per share (Q1 FY2027) vs Loss of ₹0.86 per share (Q1 FY2026)
Auditor Review
Mohandas & Associates, Chartered Accountants (ICAI Firm Registration No: 002116S) issued an unmodified review report on the interim standalone financial results. The review was conducted in accordance with Standard on Review Engagements (SRE) 2410 issued by ICAI.